An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it ‘odd’

Source: www.marketwatch.com ·
Section: business-tech ·
Bias: Center
· Published: Mon, 03 Aug 2026 20:59:00 GMT
AstraZeneca shares were slumping while Bristol-Myers Squibb’s stock was jumping on Monday on reported deal talks. But the big question is why these two pharmaceutical giants would want to come together in the first place.
Read the full article at www.marketwatch.com →
The same story across the political spectrum (15 sources)
← Back to FlashTopics.com